Key result
Recombinant human soluble thrombomodulin attenuated clot growth and clot-induced thrombin generation in human plasma by activating protein C.
Why the study?
Does recombinant human soluble thrombomodulin (rhs-TM) attenuate clot-induced coagulation in human plasma?
Does recombinant human soluble thrombomodulin (rhs-TM) attenuate clot-induced coagulation in human plasma?
Recombinant human soluble thrombomodulin attenuates clot growth in vitro by activating protein C and inhibiting further thrombin generation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for rhs-TM in human plasma; leaves open translation to clinical thrombosis management.
Recent studies have suggested that clot-bound thrombin plays an important role in thrombus growth. In this study, we examined the effects of recombinant human soluble thrombomodulin (rhsTM) on clot-induced coagulation. rhsTM enhanced the activation of protein C by clots, and attenuated clot-induced thrombin generation and fibrinopeptide A (FPA) production in a dose-dependent manner. The inhibitory effect of rhsTM was abolished by anti-protein C antibody. The inhibitory effect of rhsTM on clot-induced thrombin generation continued for over 60 min after the addition of the clot, while an active site-directed thrombin inhibitor, argatroban, produced a more transient inhibition. rhsTM also inhibited the regrowth of the clot in (125)I-fibrinogen-supplemented plasma. We also examined the effect of rhsTM by thromboelastography, rhsTM reduced the growth of the clot but had little effect on the time to begin clotting, while heparin and Fragmin (low molecular weight heparin) had effects opposite to those of rhsTM. These findings suggest that rhs-TM attenuates the growth of the clot by activating protein C and inhibiting further thrombin generation in the clot.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (1998) studied Clot-induced coagulation. Recombinant human soluble thrombomodulin (rhsTM) vs. Argatroban, heparin, and low molecular weight heparin was evaluated on Clot-induced thrombin generation and clot growth. Recombinant human soluble thrombomodulin attenuated clot growth and clot-induced thrombin generation in human plasma by activating protein C.
Synapse has enriched 10 related papers. Consider them for comparative context: